Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine agonists and Parkinson's disease.

K Burton, D B Calne

    Clinical Neurology and Neurosurgery
    |January 1, 1984
    PubMed
    Summary

    This review covers dopamine agonists for Parkinson's disease, including how they are used, their side effects, and methods for identifying them. It also examines the role of ergots in understanding dopamine receptor function.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Guidelines for a sustainable return to work with long COVID.

    Occupational medicine (Oxford, England)·2025
    Same author

    Sustaining work ability amongst female professional workers with long COVID.

    Occupational medicine (Oxford, England)·2024
    Same author

    Advice to remain active with arm pain reduces disability.

    Occupational medicine (Oxford, England)·2023
    Same author

    What workers can tell us about post-COVID workability.

    Occupational medicine (Oxford, England)·2022
    Same author

    The Development and Content of the Vocational Advice Intervention and Training Package for the Study of Work and Pain (SWAP) Trial (ISRCTN 52269669).

    Journal of occupational rehabilitation·2018
    Same author

    The future for Clinical Biomechanics.

    Clinical biomechanics (Bristol, Avon)·2016

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Parkinson's disease is a progressive neurodegenerative disorder.
    • Dopamine agonists are a key therapeutic class for managing Parkinson's symptoms.

    Purpose of the Study:

    • To review the therapeutic applications of dopamine agonists in Parkinson's disease.
    • To examine clinical guidelines for initiating these drugs.
    • To detail the adverse effects associated with dopamine agonist therapy.

    Main Methods:

    • Literature review of therapeutic uses, guidelines, and adverse effects.
    • Examination of the role of dopaminomimetic ergots.
    • Analysis of laboratory methods for dopamine agonist identification.

    Main Results:

    • Dopamine agonists are crucial in antiparkinsonian treatment regimens.
    • Ergot derivatives have been instrumental in dopamine receptor research.
    • Various laboratory techniques exist for identifying dopamine agonists.

    Conclusions:

    • Understanding dopamine agonist therapy, including guidelines and side effects, is vital for Parkinson's disease management.
    • Dopamine receptor research has advanced significantly, partly due to ergots.

    Related Experiment Videos